Immunotherapy impro...
Clear all

Immunotherapy improves prognosis for women with recurrent ovarian cancer in clinical trial

Joined: 3 years ago
Posts: 634
Topic starter  

HONOLULU (March 16, 2019) ─ Results from a recent clinical trial show that a new immunotherapy treatment, when added to standard chemotherapy, significantly prolongs survival in women with recurrent ovarian cancer. The randomized phase II trial compared overall survival of women who received chemotherapy with and without immunotherapy for recurrent ovarian cancer. Women treated with a combination of chemotherapy and immunotherapy experienced significantly prolonged survival.